193 related articles for article (PubMed ID: 37905148)
61. Disseminated Intravascular Coagulation in Acute Promyelocytic Leukemia Patients: A Retrospective Analysis of Outcomes and Healthcare Burden in US Hospitals.
Patel R; Patel D; Patel M; Ohemeng-Dapaah J; Onyechi A; Patel Z; Yang C; Shaikh S
Turk J Haematol; 2024 Mar; 41(1):1-8. PubMed ID: 38374587
[TBL] [Abstract][Full Text] [Related]
62. Neutrophil extracellular trap formation is an independent risk factor for occult cancer in patients presenting with venous thromboembolism.
Rosell A; Gautam G; Wannberg F; Ng H; Gry H; Vingbäck E; Lundström S; Mackman N; Wallén H; Westerlund E; Thålin C
J Thromb Haemost; 2023 Nov; 21(11):3166-3174. PubMed ID: 37479035
[TBL] [Abstract][Full Text] [Related]
63. Safety and efficacy of enoxaparin treatment in venous thromboembolic disease during acute leukemia.
Imberti D; Vallisa D; Anselmi E; Moroni CF; Bertè R; Lazzaro A; Bernuzzi P; Arcari AL; Cavanna L
Tumori; 2004; 90(4):390-3. PubMed ID: 15510981
[TBL] [Abstract][Full Text] [Related]
64. Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial.
O'Brien SH; Rodriguez V; Lew G; Newburger JW; Schultz CL; Orgel E; Derr K; Ranalli MA; Esbenshade AJ; Hochberg J; Kang HJ; Dinikina Y; Mills D; Donovan M; Dyme JL; Favatella NA; Mitchell LG;
Lancet Haematol; 2024 Jan; 11(1):e27-e37. PubMed ID: 37980924
[TBL] [Abstract][Full Text] [Related]
65. Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin.
Gezelius E; Flou Kristensen A; Bendahl PO; Hisada Y; Risom Kristensen S; Ek L; Bergman B; Wallberg M; Falkmer U; Mackman N; Pedersen S; Belting M
PLoS One; 2018; 13(11):e0207387. PubMed ID: 30412630
[TBL] [Abstract][Full Text] [Related]
66. Plasminogen activators and their inhibitors in leukemic cell homogenates.
Wada H; Kumeda Y; Ogasawara Z; Ohiwa M; Kaneko T; Tamaki S; Ohno T; Kageyama S; Kobayashi T; Deguchi K
Am J Hematol; 1993 Feb; 42(2):166-70. PubMed ID: 8438877
[TBL] [Abstract][Full Text] [Related]
67. Markers of hypercoagulability in children with newly diagnosed acute lymphoblastic leukemia.
Carmona R; Kizilocak H; Marquez-Casas E; Vasquez S; Ji L; Ko RH; Young G; Jaffray J
Pediatr Blood Cancer; 2022 Mar; 69(3):e29522. PubMed ID: 34963026
[TBL] [Abstract][Full Text] [Related]
68. Disseminated intravascular coagulation in acute leukemia.
Barbui T; Falanga A
Semin Thromb Hemost; 2001 Dec; 27(6):593-604. PubMed ID: 11740683
[TBL] [Abstract][Full Text] [Related]
69. Effect of α2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism.
Baráth B; Bogáti R; Miklós T; Kállai J; Mezei ZA; Bereczky Z; Muszbek L; Katona É
Thromb Res; 2021 Jul; 203():110-116. PubMed ID: 33992873
[TBL] [Abstract][Full Text] [Related]
70. C-reactive protein level predicts 30-day mortality and bleeding in patients with venous thromboembolism: A prospective single-center study.
Demelo-Rodríguez P; Galeano-Valle F; Marcelo-Ayala A; Fernández-Carracedo E; Cuenca-Zarzuela A; Gómez-Morales M; Alvarez-Sala-Walther LA; Bellón-Cano JM; Del-Toro-Cervera J
Med Clin (Barc); 2020 Jul; 155(2):51-56. PubMed ID: 31787321
[TBL] [Abstract][Full Text] [Related]
71. Preferential consumption of heparin cofactor II in disseminated intravascular coagulation associated with acute promyelocytic leukemia.
Kario K; Matsuo T; Kodama K; Katayama S; Kobayashi H
Thromb Res; 1992 May; 66(4):435-44. PubMed ID: 1412208
[TBL] [Abstract][Full Text] [Related]
72. Types, Clinical Features, and Survival Outcomes of Patients with Acute Myeloid Leukemia in Thailand: A 3-Year Prospective Multicenter Study from the Thai Acute Leukemia Study Group (TALSG).
Wanitpongpun C; Utchariyaprasit E; Owattanapanich W; Tantiworawit A; Rattarittamrong E; Niparuck P; Puavilai T; Julamanee J; Saelue P; Chanswangphuwana C; Polprasert C; Nakhakes C; Limvorapitak W; Kanitsap N; Prayongratana K; Sriswasdi C
Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):e635-e643. PubMed ID: 33926829
[TBL] [Abstract][Full Text] [Related]
73. Does cell-free DNA promote coagulation and inhibit fibrinolysis in patients with unprovoked venous thromboembolism?
Medeiros SK; Emery B; Bhagirath V; Parpia S; Dwivedi DJ; Dwivedi NJ; Kearon C; Liaw PC
Thromb Res; 2020 Feb; 186():13-19. PubMed ID: 31838139
[TBL] [Abstract][Full Text] [Related]
74. Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.
Sundquist K; Wang X; Svensson PJ; Sundquist J; Hedelius A; Larsson Lönn S; Zöller B; Memon AA
Thromb Haemost; 2015 Nov; 114(6):1156-64. PubMed ID: 26245493
[TBL] [Abstract][Full Text] [Related]
75. Plasminogen activator inhibitor-1, thrombin-antithrombin, and prothrombin fragment F1+2 have higher diagnostic values than D-dimer for venous thromboembolism after TKA.
Yang Y; Feng G; Yan J; Wu L; Wang F; Ding D; Wang H; Jin Q
Clin Appl Thromb Hemost; 2022; 28():10760296221097383. PubMed ID: 35535394
[TBL] [Abstract][Full Text] [Related]
76. Simplified predictive scores for thrombosis and bleeding complications in newly diagnosed acute leukemia patients.
Owattanapanich W; Rungjirajittranon T; Jantataeme A; Kungwankiattichai S; Ruchutrakool T
Thromb J; 2023 Jun; 21(1):65. PubMed ID: 37291589
[TBL] [Abstract][Full Text] [Related]
77. Recurrence of venous thromboembolism among adults acute leukemia patients treated at the University of Texas MD Anderson Cancer Center: Incidence and risk factors.
Luong NV; Kroll MH; Vu K
Thromb Res; 2017 Aug; 156():14-19. PubMed ID: 28577388
[TBL] [Abstract][Full Text] [Related]
78. Comparison Between Non-vitamin K Antagonist Oral Anticoagulants and Low-Molecular-Weight Heparin in Asian Individuals With Cancer-Associated Venous Thromboembolism.
Chen DY; Tseng CN; Hsieh MJ; Lan WC; Chuang CK; Pang ST; Chen SW; Chen TH; Chang SH; Hsieh IC; Chu PH; Wen MS; Chen JS; Chang JW; See LC; Huang WK
JAMA Netw Open; 2021 Feb; 4(2):e2036304. PubMed ID: 33533929
[TBL] [Abstract][Full Text] [Related]
79. D-dimer and risk for thrombosis in adults with newly diagnosed acute lymphoblastic leukemia.
Anderson DR; Stock W; Karrison TG; Leader A
Blood Adv; 2022 Sep; 6(17):5146-5151. PubMed ID: 35728059
[TBL] [Abstract][Full Text] [Related]
80. New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia.
Tallman MS; Hakimian D; Kwaan HC; Rickles FR
Leuk Lymphoma; 1993 Sep; 11(1-2):27-36. PubMed ID: 8220153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
